Riociguat

Adempas

Soluble Guanylate Cyclase Stimulator

NADAC/unit N/A

No Shortage Tier 1: 89.7% PA Req: 500.0% 1 Manufacturers 5 ANDAs

Adempas is a soluble guanylate cyclase (sGC) stimulator indicated for the treatment of adults with: • Persistent/recurrent Chronic Thromboembolic Pulmonary Hypertension (CTEPH) (WHO Group 4) after ....

Covered Lives

Generic Manufacturers

BAYER HEALTHCARE PHARMACEUTICALS INCMSN LABORATORIES PRIVATE LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Riociguat drfinder.aiFind doctors who prescribe Riociguat rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Riociguat

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.